Isabelle Lochon
Impact in
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 8
- Lung Cancer Research Studies 4
- Cancer Treatment and Pharmacology 3
-
- Chemotherapy-induced organ toxicity mitigation 4
- Co-authors
- Étienne Chatelut (17 shared papers)Roland Bugat (8 shared papers)Pierre Canal (9 shared papers)Sylvie Mireille Guichard (3 shared papers)Isabelle Hennebelle (3 shared papers)Gwénaël Ferron (3 shared papers)P Chevreau (1 shared paper)Janick Sèlves (1 shared paper)
- Journals
- Cancer Chemotherapy and Pharmacology (8 papers)British Journal of Cancer (3 papers)British Journal of Clinical Pharmacology (1 paper)European Journal of Clinical Pharmacology (1 paper)Oncology (1 paper)
- Partner nations
- FranceUnited States
In The Last Decade
Isabelle Lochon
21 papers receiving 650 citations
Peers
Comparison fields: 5 of 74
- Oncology 288
- Pharmacology 46
- Reproductive Medicine 36
- Emergency Medicine 34
- Hepatology 29
Countries citing papers authored by Isabelle Lochon
This map shows the geographic impact of Isabelle Lochon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Lochon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Lochon more than expected).
Fields of papers citing papers by Isabelle Lochon
This network shows the impact of papers produced by Isabelle Lochon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Lochon. The network helps show where Isabelle Lochon may publish in the future.
Co-authors
The 25 scholars most cited alongside Isabelle Lochon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 125 | |
| 2 | 1998 | 60 | |
| 3 | 1997 | 56 | |
| 4 | 2004 | 53 | |
| 5 | 2009 | 48 | |
| 6 | 2008 | 37 | |
| 7 | 2014 | 34 | |
| 8 | 2015 | 34 | |
| 9 | 1999 | 32 | |
| 10 | 2007 | 32 | |
| 11 | 2000 | 31 | |
| 12 | 1997 | 30 | |
| 13 | 2002 | 25 | |
| 14 | 2005 | 23 | |
| 15 | 1998 | 21 | |
| 16 | 2006 | 13 | |
| 17 | 2005 | 12 | |
| 18 | 1998 | 5 | |
| 19 | 2018 | 5 | |
| 20 | 2011 | 4 |
About Isabelle Lochon
Isabelle Lochon is a scholar working on Oncology, Pathology and Forensic Medicine, Pharmacology, Molecular Biology and Epidemiology, having authored 21 papers that have together received 683 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (5 papers), Lung Cancer Research Studies (4 papers), Chemotherapy-induced organ toxicity mitigation (4 papers), Cancer Treatment and Pharmacology (3 papers), Intraperitoneal and Appendiceal Malignancies (3 papers), Neuroendocrine Tumor Research Advances (2 papers), Retinoids in leukemia and cellular processes (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). The work is most often cited by research in Oncology (288 citations), Pharmacology (46 citations), Reproductive Medicine (36 citations), Emergency Medicine (34 citations) and Hepatology (29 citations). Isabelle Lochon has collaborated with scholars based in France and United States. Frequent co-authors include Étienne Chatelut, Roland Bugat, Pierre Canal, Sylvie Mireille Guichard, Isabelle Hennebelle, Gwénaël Ferron, P Chevreau, Janick Sèlves, Catherine TERRET and Mondher Mahjoubi. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, British Journal of Cancer, British Journal of Clinical Pharmacology, European Journal of Clinical Pharmacology and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.